Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.125
+0.001 (0.81%)
Apr 29, 2026, 3:58 PM HKT
-63.24%
Market Cap 208.07M
Revenue (ttm) 1.08B
Net Income (ttm) -45.33M
Shares Out 1.68B
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 570,000
Average Volume 184,500
Open 0.123
Previous Close 0.124
Day's Range 0.123 - 0.126
52-Week Range 0.119 - 0.380
Beta -0.10
RSI 37.19
Earnings Date Mar 25, 2026

About HKG:8329

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. It also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology busine... [Read more]

Sector Healthcare
Founded 2002
Employees 1,382
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8329
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.